Histaglobin

Country of origin - Switzerland
Pharm-Group - Immunoglobulins

Manufacturers - Biobasal AG (Switzerland)
International name - Normal human immunoglobulin + Histamine
Synonyms - Histaglobin triplex
Dosage forms - lyophilized powder for the preparation of injection solution
Composition - Normal human immunoglobulin + histamine hydrochloride + sodium thiosulfate
Indications for use - Allergic diseases of various origins: respiratory (bronchial asthma, hay fever, non-seasonal (year-round) allergic rhinitis), skin (eczema and urticaria, neurodermatitis), neurological (certain forms of migraine); some forms of premenstrual syndrome, etc. Low doses (Histaglobin) are especially recommended for children and adolescents; higher doses (Histaglobin triplex) are more often indicated for complicated asthma, severe hay fever or chronic recurrent allergic diseases, as well as in patients with no positive effect after the first course of treatment.
Contraindications - Hypersensitivity to whey proteins, infection (local, generalized), exacerbation of bronchial asthma, eczema, etc., selective IgA deficiency, pregnancy, lactation.
Side effect - Exacerbation of diseases after 1-2 injections, pain at the injection site (eliminate with symptomatic means).
Interaction - Compatible with antiallergic and desensitizing nonspecific therapy.
Overdose - Even with daily administration of the drug, no overdose phenomena were observed.
Special instructions - Before starting treatment, it is recommended to conduct a course of treatment for local or systemic infections. Cannot be administered intravenously.
Literature - Encyclopedia of Medicines 1999.